mecamylamine has been researched along with dronabinol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lichtman, AH; Martin, BR; Smith, FL | 1 |
| Aso, E; Balerio, GN; Berrendero, F; Maldonado, R; Murtra, P | 1 |
| Fratta, W; Goldberg, SR; Scherma, M; Solinas, M; Tanda, G; Wertheim, CE | 1 |
| Hiranita, T; Nawata, Y; Sakimura, K; Yamamoto, T | 1 |
| Cole, M; Harvey, EL; Javadi-Paydar, M; Kerr, TM; Taffe, MA | 1 |
1 review(s) available for mecamylamine and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for mecamylamine and dronabinol
| Article | Year |
|---|---|
Evidence that the antinociceptive tail-flick response is produced independently from changes in either tail-skin temperature or core temperature.
Topics: Analgesics; Animals; Body Temperature; Dronabinol; Hot Temperature; Immersion; Male; Mecamylamine; Mice; Mice, Inbred ICR; Morphine; Pain Measurement; Skin Temperature; Tail | 1993 |
Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Benzoxazines; Brain; Calcium Channel Blockers; Cell Count; Conditioning, Operant; Dronabinol; Drug Administration Schedule; Drug Interactions; Immunohistochemistry; In Vitro Techniques; Male; Mecamylamine; Mice; Morpholines; Motivation; Naloxone; Naphthalenes; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Proto-Oncogene Proteins c-fos; Radioligand Assay; Substance Withdrawal Syndrome | 2004 |
Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Topics: Animals; Arachidonic Acids; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mecamylamine; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pilocarpine; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB1; Receptors, Muscarinic; Receptors, Nicotinic; Reinforcement, Psychology; Scopolamine | 2007 |
Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors.
Topics: Acetylcholine; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Cerebral Cortex; Cholinergic Antagonists; Conditioning, Operant; Dose-Response Relationship, Drug; Dronabinol; Excitatory Amino Acid Antagonists; Inhibition, Psychological; Male; Mecamylamine; Methamphetamine; Nucleus Accumbens; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Self Administration | 2008 |
Effects of nicotine and THC vapor inhalation administered by an electronic nicotine delivery system (ENDS) in male rats.
Topics: Administration, Inhalation; Animals; Body Temperature; Central Nervous System Stimulants; Dronabinol; Electronic Nicotine Delivery Systems; Locomotion; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Tobacco Use Disorder | 2019 |